Skip to content

NIH Clinical Trial Integrity Act

In committee: it can still change before the session ends.

US S 3564 · Senate Bill · 119th Congress

Draft a letter
Stage
In committee
Started in
Senate
Sponsors
2
Latest action
Dec 18, 2025

What it does

The NIH Clinical Trial Integrity Act would require NIH-funded research organizations conducting clinical trials for drugs, devices, biological products, or behavioral interventions to submit applications that include clear, measurable goals for recruiting and retaining participants reflecting the race, ethnicity, age, and sex of affected patients or the general U.S. population, along with detailed plans and rationales for achieving those goals. It mandates annual reporting of disaggregated demographic data, completion of diversity training by researchers, and sharing of final participant counts by demographic group, while protecting participant privacy. The bill also directs HHS to study…

No official summary is available here. This one was written by AI from the bill’s text.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Dec 18, 2025

  2. Committee (Current step)

    In committee · Dec 18, 2025

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

NIH Clinical Trial Integrity Act | 52